Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 30, 2003

View Archived Issues

Shire BioChem scientists report new agents for hepatitis C virus

Novel antifungal macrolides isolated and tested by Ajinomoto scientists

Calcium antagonists and their use in IBS reported by Ajinomoto

Ono identifies novel cysteine protease inhibitors

Boehringer Ingelheim claims new cathepsin inhibitors for osteoporosis, arthritis, etc.

HMG-CoA-inhibitory simvastatin analogues covered by Ranbaxy patent

New CRF1 receptor modulators and their use in anxiety, depression and bowel disorders

Allosteric AMPA modulators discovered by Boehringer Ingelheim researchers

Phase II Liprostin study cleared to begin

GTx and Wyeth enter agreement for VSV-based therapeutics and vaccines

Genome Therapeutics and MerLion form antiinfective drug discovery collaboration

Solvay and Innogenetics extend research collaboration

Epicyte advances production of human HIV antibodies in plants

NicOx and Biolipox expand research on NO-donating respiratory drugs

Tarceva phase III trial in pancreatic cancer achieves target enrollment

AlphaRx acquires exclusive rights to VT-1

Alliance and Baxter to restructure Oxygent agreement

High-affinity sigma receptor ligand SSR-125392A effective in animal models of GVHD and RA

Ref-1/AP-1 validated as therapeutic target for asthma in recent PNAS article

FDA issues complete response letter for Aldurazyme

U.S. phase II trial of antibody targeting IL-15 cleared

First clinical study of IPL-512602 under way in the U.S.

Second filing announced for YM-905

Amylin acquires rights to GLP-1 program from Restoragen

Triangle now part of Gilead

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...